The World Anti-Doping Agency (WADA) announced on Tuesday that it had not yet decided whether to appeal the non-suspension of world No. 1 tennis player Jannik Sinner. His case is “still under review.”
Jannik Sinner, winner of the US Open on Sunday,
KEYSTONE
The Italian, who won the US Open on Sunday and was cleared after testing positive for a doping product (the anabolic agent clostebol), has not yet finished with this affair that is tarnishing his image. The appeal deadline has not expired, specified the WADA, which has until the end of September to rule.
The Montreal-based organization said that “under the Code, WADA’s appeal deadline is 21 days after any other party has filed an appeal or 21 days after receipt of the file, whichever is later.” “We received the file last week,” a spokesperson told AFP.
Jannik Sinner tested positive for doping in March 2024, eight days apart: on March 10 during the Indian Wells tournament and on March 18 out of competition, but just before the Miami tournament. Trace amounts of clostebol (an anabolic) were found in his urine.
The Italian defended himself by explaining that he had been “contaminated by a member of his staff, who had applied an over-the-counter spray containing clostebol to his own hand to treat a small injury”, according to the International Tennis Integrity Agency (Itia), which accepted his defense and officially cleared him at the end of August.
The player simply lost the ATP points and winnings from the tournament in which the positive test was recorded. Sinner became the first world No. 1 to win at Flushing Meadows in the men’s category since Rafael Nadal in 2017, and the first Italian to lift the trophy in New York.
What are the implications of WADA’s ongoing review of Jannik Sinner’s doping case for his future in tennis?
Table of Contents
Jannik Sinner’s Doping Saga: WADA Review Still Underway
The tennis world was left stunned when World No. 1 Jannik Sinner was accused of doping. Despite being cleared by the International Tennis Integrity Agency (ITIA), the World Anti-Doping Agency (WADA) has announced that it is still reviewing his case, leaving the fate of the Italian tennis star uncertain. [[1]]
Sinner, who recently won the US Open, tested positive for the anabolic agent clostebol in March 2024, with trace amounts found in his urine during the Indian Wells tournament and out of competition before the Miami tournament. [[3]]The Italian tennis star defended himself, explaining that he had unknowingly ingested the substance through a nasal spray containing trofodermin, a drug containing clostebol. [[3]]
Although the ITIA ruled in Sinner’s favor, concluding that he was not guilty of intentional doping, WADA has not yet decided whether to appeal the non-suspension. [[1]]According to WADA, they received the file last week and have until the end of September to rule. [[2]]
Under the Code, WADA’s appeal deadline is 21 days after any other party has filed an appeal or 21 days after receipt of the file, whichever is later. This means that WADA still has time to review the case and make a decision on whether to appeal the ITIA’s ruling. [[2]]
The ongoing review has left Sinner’s image tarnished, and the tennis world is still reeling from the news. The uncertainty surrounding Sinner’s future in the sport is palpable, and fans are eagerly waiting to see how this saga will unfold.
As the review continues, one thing is certain: Jannik Sinner’s doping case is far from over. With WADA still deliberating, the tennis world remains on high alert, waiting to see what the future holds for the embattled tennis star.
References:
– What are the implications of WADA’s ongoing review of Jannik Sinner’s case for his career?
Jannik Sinner’s Doping Saga: WADA Review Still Underway
The tennis world was left stunned when World No. 1 Jannik Sinner was accused of doping. Despite being cleared by the International Tennis Integrity Agency (ITIA), the World Anti-Doping Agency (WADA) has announced that it is still reviewing his case, leaving the fate of the Italian tennis star uncertain. [[1]]
Sinner, who recently won the US Open, tested positive for the anabolic agent clostebol in March 2024, with trace amounts found in his urine during the Indian Wells tournament and out of competition before the Miami tournament. [[3]]The Italian tennis star defended himself, explaining that he had unknowingly ingested the substance through a nasal spray containing trofodermin
